[HTML][HTML] Molecular characterization of bladder cancer in smokers versus nonsmokers
Smoking is considered an important risk factor for bladder cancer (BC), yet molecular
characterization of BC in nonsmokers has not been extensively studied. Here, we compare …
characterization of BC in nonsmokers has not been extensively studied. Here, we compare …
[PDF][PDF] Molecular profiling of infiltrating urothelial carcinoma of the bladder
SZ Millis, D Bryant, G Basu, R Bender… - Journal of Clinical …, 2014 - carislifesciences.com
Background: Infiltrating urothelial carcinoma (UC) is the most common variant of urinary
bladder cancer. The prognosis for muscle infiltrating or metastatic UC of the bladder is poor …
bladder cancer. The prognosis for muscle infiltrating or metastatic UC of the bladder is poor …
Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients
Background Bladder cancer is the fifth most common cancer in the United States and
smoking is the largest known risk factor. Tobacco-derived carcinogens may induce the …
smoking is the largest known risk factor. Tobacco-derived carcinogens may induce the …
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
LC Kompier, I Lurkin, MNM van der Aa, BWG van Rhijn… - PloS one, 2010 - journals.plos.org
Background Fifty percent of patients with muscle–invasive bladder cancer (MI-BC) die from
their disease and current chemotherapy treatment only marginally increases survival. Novel …
their disease and current chemotherapy treatment only marginally increases survival. Novel …
Does Smoking Cessation Reduce Bladder Cancer Recurrence?
KH Gessner, DR Siemens, MA Bjurlin - Journal of Urology, 2022 - journals.lww.com
Smoking status has been associated with both an increased risk of developing bladder
cancer and worse prognosis, but its impact on the risk of nonmuscleinvasive bladder cancer …
cancer and worse prognosis, but its impact on the risk of nonmuscleinvasive bladder cancer …
Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program
AP Mitra, JE Castelao, D Hawes, DD Tsao‐Wei… - Cancer, 2013 - Wiley Online Library
BACKGROUND: Traditional single‐marker and multimarker molecular profiling approaches
in bladder cancer do not account for major risk factors and their influence on clinical …
in bladder cancer do not account for major risk factors and their influence on clinical …
Smoking intensity and bladder cancer aggressiveness at diagnosis
ALA Barbosa, SHHM Vermeulen, KK Aben… - PLoS …, 2018 - journals.plos.org
Objective To explore the relation between cigarette smoking intensity and bladder cancer
aggressiveness at first diagnosis. Methods Patients diagnosed with urinary bladder cancer …
aggressiveness at first diagnosis. Methods Patients diagnosed with urinary bladder cancer …
Tumor genomic landscape in smokers compared to non-smoker patients with locally advanced or metastatic urothelial carcinoma.
554 Background: Cigarette smoking is a known risk factor for bladder cancer. Smokers have
been reported to have greater ERCC2-Signature mutations and APOBEC-Signature 13 …
been reported to have greater ERCC2-Signature mutations and APOBEC-Signature 13 …
Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer
Y Ling, J Li, L Zhou - International journal of …, 2023 - journals.sagepub.com
Objective Epidemiologic studies have linked smoking to various malignancies, including
bladder cancer, but its underlying biological functions remain elusive. Currently, we aimed to …
bladder cancer, but its underlying biological functions remain elusive. Currently, we aimed to …
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
F Anari, B Miron, D Henson, D Arguello, ER Plimack… - 2019 - ascopubs.org
399 Background: Adenocarcinoma (ADA) and squamous cell carcinoma (SCC) are rare,
aggressive subtypes of bladder cancer, for which no clear standard of care exists. We report …
aggressive subtypes of bladder cancer, for which no clear standard of care exists. We report …